New Standards in Diffuse Lower-Grade Gliomas: Integrative Management From Surgery to Survivorship
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
New Standards in Diffuse Lower-Grade Gliomas: Integrative Management From Surgery to Survivorship
-
Narrated by:
-
By:
About this listen
Which patients with IDH-mutant glioma should receive an isocitrate dehydrogenase (IDH) inhibitor? A top neurosurgeon weighs in.
Credit available for this activity expires: 6/9/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002598?ecd=bdc_podcast_libsyn_mscpedu
No reviews yet